NL8700366A - Combinatie van fu met bvdu als middel tegen adenocarcinoom. - Google Patents

Combinatie van fu met bvdu als middel tegen adenocarcinoom. Download PDF

Info

Publication number
NL8700366A
NL8700366A NL8700366A NL8700366A NL8700366A NL 8700366 A NL8700366 A NL 8700366A NL 8700366 A NL8700366 A NL 8700366A NL 8700366 A NL8700366 A NL 8700366A NL 8700366 A NL8700366 A NL 8700366A
Authority
NL
Netherlands
Prior art keywords
fluorouracil
bvdu
bromovinyl
combination
deoxyuridine
Prior art date
Application number
NL8700366A
Other languages
English (en)
Dutch (nl)
Original Assignee
Stichting Rega V Z W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega V Z W filed Critical Stichting Rega V Z W
Priority to NL8700366A priority Critical patent/NL8700366A/nl
Priority to JP63031681A priority patent/JP2688057B2/ja
Priority to US07/154,193 priority patent/US4894365A/en
Priority to ES88200265T priority patent/ES2032942T3/es
Priority to EP88200265A priority patent/EP0283065B1/en
Priority to AT88200265T priority patent/ATE63817T1/de
Priority to DE8888200265T priority patent/DE3862961D1/de
Publication of NL8700366A publication Critical patent/NL8700366A/nl
Priority to US07/373,824 priority patent/US4988678A/en
Priority to GR91401120T priority patent/GR3002431T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NL8700366A 1987-02-13 1987-02-13 Combinatie van fu met bvdu als middel tegen adenocarcinoom. NL8700366A (nl)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NL8700366A NL8700366A (nl) 1987-02-13 1987-02-13 Combinatie van fu met bvdu als middel tegen adenocarcinoom.
JP63031681A JP2688057B2 (ja) 1987-02-13 1988-02-10 抗腺がん剤
US07/154,193 US4894365A (en) 1987-02-13 1988-02-11 Combinations of FU and BVU as anti-adenocarcinoma agents
ES88200265T ES2032942T3 (es) 1987-02-13 1988-02-12 Un procedimiento para preparar un medicamento para uso contra adenocarcinomas.
EP88200265A EP0283065B1 (en) 1987-02-13 1988-02-12 Combinations of fu and bvu as anti-adenocarcinoma agents
AT88200265T ATE63817T1 (de) 1987-02-13 1988-02-12 Mischungen von fu und bvu als adenokarzinomhemmende mittel.
DE8888200265T DE3862961D1 (de) 1987-02-13 1988-02-12 Mischungen von fu und bvu als adenokarzinomhemmende mittel.
US07/373,824 US4988678A (en) 1987-02-13 1989-06-29 Combinations of FU and BVU as anti-adenocarcinoma agents
GR91401120T GR3002431T3 (en) 1987-02-13 1991-08-02 Combinations of fu and bvu as anti-adenocarcinoma agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8700366A NL8700366A (nl) 1987-02-13 1987-02-13 Combinatie van fu met bvdu als middel tegen adenocarcinoom.
NL8700366 1987-02-13

Publications (1)

Publication Number Publication Date
NL8700366A true NL8700366A (nl) 1988-09-01

Family

ID=19849574

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8700366A NL8700366A (nl) 1987-02-13 1987-02-13 Combinatie van fu met bvdu als middel tegen adenocarcinoom.

Country Status (8)

Country Link
US (2) US4894365A (ja)
EP (1) EP0283065B1 (ja)
JP (1) JP2688057B2 (ja)
AT (1) ATE63817T1 (ja)
DE (1) DE3862961D1 (ja)
ES (1) ES2032942T3 (ja)
GR (1) GR3002431T3 (ja)
NL (1) NL8700366A (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137724A (en) * 1990-05-23 1992-08-11 Stichting Rega Vzw Combinations of TS-inhibitors and viral TK-inhibitors in antiherpetic medicines
EP0806956B1 (de) * 1995-02-01 2002-08-28 RESprotect GmbH Verwendung von 5' substituierten nukleosiden zur hemmung von resistenzbildung bei der zytostatikabehandlung
ATE413881T1 (de) 1997-08-08 2008-11-15 Celmed Oncology Usa Inc Verfahren und zubereitungen um resistenz gegen biologische oder chemische therapien zu überwinden
IL137164A0 (en) 1998-01-23 2001-07-24 Newbiotics Inc Enzyme catalyzed therapeutic agents
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
AU774492B2 (en) 1999-07-22 2004-07-01 Celmed Oncology (Usa) Inc. Methods for treating therapy-resistant tumors
AU2451601A (en) * 1999-12-23 2001-07-03 Newbiotics, Inc. Use of bvdu for inhibiting the growth of hyperproliferative cells
DE10108851A1 (de) * 2001-02-23 2002-09-12 Resprotect Gmbh Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale
DE3667915D1 (de) * 1985-01-30 1990-02-08 Hoffmann La Roche Pharmazeutische zusammensetzung.

Also Published As

Publication number Publication date
GR3002431T3 (en) 1992-12-30
EP0283065A1 (en) 1988-09-21
EP0283065B1 (en) 1991-05-29
JP2688057B2 (ja) 1997-12-08
US4988678A (en) 1991-01-29
JPS63203619A (ja) 1988-08-23
DE3862961D1 (de) 1991-07-04
ES2032942T3 (es) 1996-07-16
US4894365A (en) 1990-01-16
ATE63817T1 (de) 1991-06-15

Similar Documents

Publication Publication Date Title
DE60105424T2 (de) Methoden zur behandlung von delta hepatitis virus infektionen mit beta-l-2' deoxy-nucleosiden
JPH10511689A (ja) アシル化ピリミジンヌクレオシドによる化学療法剤および抗ウイルス剤の毒性を減少させる方法
WO1999051246A1 (fr) Agents antitumoraux
JP2584947B2 (ja) アシル化ピリミジンヌクレオシドによる化学療法剤および抗ウイルス剤毒性の治療
EP0281380B1 (en) Synergistic interplay of interleukin-2 and dsRNAs
NL8700366A (nl) Combinatie van fu met bvdu als middel tegen adenocarcinoom.
NL8301913A (nl) Middel voor het versterken van de antitumor activiteit van een middel tegen tumoren.
Eriguchi et al. Pilot study for preoperative administration of 1-OHP to patients with advanced scirrhous type gastric cancer
Kimura et al. Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2′-tetrahydrofuryl)-5-fluorouracil
JP2002515892A (ja) サイトカインが関係する疾患治療法
Vadlamudi et al. Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice
LV10574B (en) The therapeutic use of low concentrations of trinitrobenzene, carminic acid and their derivatives as anti-cancer and anti-viral agents
JP3482418B2 (ja) 細胞障害性制癌剤の副作用軽減および制癌作用増強剤
Saijo et al. Changes in serum erythropoietin levels during chemotherapy for lung cancer
US7671038B1 (en) Method of therapeautic treatments including human immunodeficiency virus (HIV) disease and other conditions in a human host by administering adenine nucleotides
AU2017212224B2 (en) New method of treating bacterial infections
JPS6231690B2 (ja)
JPH0145450B2 (ja)
JPS6337767B2 (ja)
JPH0332528B2 (ja)
JPH02235813A (ja) 抗腫瘍剤
JPS6257165B2 (ja)
JPS6345372B2 (ja)
DE3007777A1 (de) Verwendung von 5-trifluormethyl-2'-desoxycytidin bei der bekaempfung von tumoren
WO2009119092A1 (ja) シチジン誘導体及びカルボプラチンを含有する抗腫瘍剤

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed